erucic acid

Subscribe to Selected New Research on erucic acid

44 relevant articles (3 outcomes, 2 trials/studies) found for this Bio-Agent

Description: RN given for parent cpd without isomeric designation

Also Known As:

13-docosenoic acid; erucic acid, (E)-isomer; erucic acid, (Z)-isomer; erucic acid, potassium salt, (Z)-isomer; erucic acid, sodium salt, (Z)-isomer

Relationship Network

Bio-Agent Context: Research Results

Lipids: 13324

Fatty Acids: 4669

Unsaturated Fatty Acids: 2223

Monounsaturated Fatty Acids: 150

Erucic Acids: 3

erucic acid: 44

Experts

1.	Hanefeld, F: 1 article (03/2000)
2.	Korenke, G C: 1 article (03/2000)
3.	Peters, A: 1 article (03/2000)
4.	Pour, R B: 1 article (03/2000)
5.	Stöckler-Ipsiroglu, S: 1 article (03/2000)
6.	Gahr, M: 1 article (03/2000)
7.	Pabst, W: 1 article (03/2000)
8.	Hunneman, D H: 1 article (03/2000)

Related Diseases

1.	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/24/1992 - "Erucic acid (C22:l fatty acid) has been found to be useful in the treatment of adrenoleukodystrophy (ALD)" 11/01/1989 - "We investigated the biochemical and clinical efficacy of dietary erucic acid (C22:1) therapy for X-linked adrenoleukodystrophy (ALD)" 05/01/2008 - "Because X-linked adrenoleukodystrophy is treated using erucic acid (22:1n-9), we assessed its metabolism in rat liver and heart following infusion of [14-(14)C]22:1n-9 (170 Ci/kg) under steady-state-like conditions" 04/01/1996 - "Effect of erucic acid on platelets in patients with adrenoleukodystrophy." 11/01/1994 - "Ten Japanese boys with childhood adrenoleukodystrophy (ALD), one adult patient with adrenomyeloneuropathy (AMN), and two presymptomatic ALD boys were treated with dietary erucic acid (C22:1) for more than 12 months; except in a case of childhood ALD patient who died 7 months after beginning erucic acid therapy" Order ALL the reference details at left...
2.	Lipidoses 01/01/1978 - "Preliminary studies at our institute indicate lipidosis in the heart both in rats fed RSO and HMO, containing equivalent amounts of erucic acid and erucic acid isomers respectively" 08/01/1992 - "Effects of dietary saturated fat on erucic acid induced myocardial lipidosis in rats." 07/01/1983 - "The acute lipidosis was reversible with either continued feeding of erucic acid for several weeks or conversion to a normal diet" 07/01/1983 - "Induction of a reversible cardiac lipidosis by a dietary long-chain fatty acid (erucic acid)" 01/01/1992 - "Although there are no indications of erucic acid toxicity in man, it is known to cause cardiac lipidosis and necrosis in rats" Order ALL the reference details at left...
3.	Demyelinating Diseases (Demyelinating Disease) 11/01/1989 - "We conclude that dietary erucic acid therapy is effective in lowering plasma C26:0 to normal in ALD patients, and may prevent further demyelination in some mildly affected boys." Order ALL the reference details at left...
4.	Thrombocytopenia (Thrombopenia) 01/01/1998 - "We conclude that the thrombocytopenia in AMN patients using Lorenzo'soil is associated with circulating platelets that have an increased erucic acid content, size and activation status" 02/01/1995 - "Profound thrombocytopenia complicating dietary erucic acid therapy for adrenoleukodystrophy." 10/01/1993 - "Thrombocytopenia induced by erucic acid therapy in patients with X-linked adrenoleukodystrophy." 05/01/1994 - "Thrombocytopenia, hepatic transaminase abnormalities, anemia and leukopenia developed during the subsequent course of therapy with oleic acid and erucic acid." 01/01/1998 - "Patients with X-ALD have been treated with Lorenzo's oil, a 4:1 combination of oleic acid and erucic acid, with thrombocytopenia as the main side effect and sometimes leading to a hemorrhagic diathesis" Order ALL the reference details at left...
5.	Necrosis 03/01/1988 - "There was a significance (P less than 0.05) in the incidence of myocardial necrosis among male rats fed increased levels of erucic acid for one week, but the response was not linear to the increase in dietary erucic acid" 01/01/1992 - "Although there are no indications of erucic acid toxicity in man, it is known to cause cardiac lipidosis and necrosis in rats" 07/01/1975 - "There was no correlation between the number of foci of myocardial necrosis and fibrosis and the state of refinement of the oils, but there were generally fewer lesions in rats fed those oils having the lowest levels of erucic acid." 07/01/1975 - "Focal myocardial necrosis and fibrosis occurred in male rats fed rapeseed oils containing different levels of erucic acid for 112 days" 07/01/1976 - "We have postulated that linolenic acid plays a role in the etiology of cardiac necrosis observed when rats are fed diets containing low erucic acid rapeseed oils." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Carnitine (L-Carnitine)
2.	Fatty Acids (Saturated Fatty Acids)
3.	Enzymes
4.	mustard oil
5.	rapeseed oil
6.	Triglycerides (Triacylglycerol)
7.	Oleic Acid (Oleate)
8.	Lorenzo's oil
9.	adrenic acid (7,10,13,16-docosatetraenoic acid)
10.	Soybean Oil

Related Therapies and Procedures

1.	Bone Marrow Transplantation (Transplantation, Bone Marrow)
2.	Diet Therapy (Therapy, Diet)

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>